1. Home
  2. UTL vs PCRX Comparison

UTL vs PCRX Comparison

Compare UTL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNITIL Corporation

UTL

UNITIL Corporation

N/A

Current Price

$53.17

Market Cap

906.9M

Sector

Utilities

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$24.66

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTL
PCRX
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.9M
1.1B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
UTL
PCRX
Price
$53.17
$24.66
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$56.50
$30.25
AVG Volume (30 Days)
85.8K
399.9K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
3.65%
N/A
EPS Growth
1.37
107.44
EPS
2.11
0.19
Revenue
$536,000,000.00
$541,533,000.00
Revenue This Year
$5.43
$6.78
Revenue Next Year
$4.22
$8.54
P/E Ratio
$24.87
$128.71
Revenue Growth
8.33
26.04
52 Week Low
$45.17
$18.80
52 Week High
$57.26
$27.66

Technical Indicators

Market Signals
Indicator
UTL
PCRX
Relative Strength Index (RSI) 39.79 42.74
Support Level $52.10 $21.97
Resistance Level $53.80 $26.93
Average True Range (ATR) 0.99 0.70
MACD -0.14 -0.20
Stochastic Oscillator 20.25 24.69

Price Performance

Historical Comparison
UTL
PCRX

About UTL UNITIL Corporation

Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: